**Core tip:** Syphilitic myelitis is a very rare manifestation of neurosyphilis. Early diagnosis and treatment are crucial because it represents a treatable and potentially reversible cause of myelopathy if treated with penicillin. Herein, we report a 25-year-old young man presenting with symptoms of sensory disturbance, due to syphilitic myelitis with longitudinally extensive myelopathy with \"flip-flop sign\" on spinal magnetic resonance imaging. Furthermore, we summarized the clinical features of syphilitic myelitis with longitudinally extensive myelopathy by reviewing the relevant literature. Our study also raises awareness of an important complication of neurosyphilis due to homosexuality. Attention is drawn upon the importance of doing serological tests for syphilis when any atypical neurological disorders are presented.

INTRODUCTION
============

Syphilis is a sexually-transmitted disease caused by *Treponema pallidum* infection. About 2.1 million pregnant women have active syphilis every year\[[@B1]\]. It is both individual and public health issues due to its direct morbidity, increased risk of human immunodeficiency virus (HIV) infection, and lifelong morbidity especially in low-income countries\[[@B2]\]. It could progress over years through a series of clinical stages and result in irreversible neurological complications without treatment. Syphilis continues to be a major public health problem all over the world.

One-third of patients with early syphilis have the manifestations of the central nervous system, and the recent resurgence in syphilis has seen an accompanying increase in cases of neurosyphilis. It can also affect the brain, brainstem, spinal cord, meninges, nerve roots, and cerebral/spinal vessels\[[@B3]\]. The clinical presentations of neurosyphilis include acute lymphocytic meningitis (acute syphilitic meningitis), stroke (meningovascular syphilis), dementia (general paresis), and/or myelopathy (tabes dorsalis, meningomyelitis, and syringomyelia)\[[@B4]\]. The clinical symptoms of syphilitic meningomyelitis usually develop at between 1 and 30 years after the initial infection\[[@B5]\]. The treatment with penicillin and corticosteroids can diminish the affected lesions with partially reversible changes. However, symptomatic neurosyphilis, especially syphilitic myelitis, and its clinical features have been infrequently reported\[[@B6]\].

Only quite a few cases of syphilitic myelitis have been documented in the reported literature. To the best of our knowledge, there are only 19 reported cases of syphilitic myelitis in the literature\[[@B4],[@B7]-[@B21]\]. We herein report a case of syphilitic myelitis with longitudinally extensive myelopathy presenting with the characteristic of \"flip-flop sign\" on spinal magnetic resonance imaging (MRI). We also summarized the clinical features of syphilitic myelitis with longitudinally extensive myelopathy based on the prior reported literature.

MATERIALS AND METHODS
=====================

Case presentation
-----------------

A 25-year-old man was admitted to the Department of Neurology with the symptoms of acute onset of sensory disturbance and numbness for 7 d. He was homosexual and exposed to unprotected intercourse. A neurological examination revealed hypalgesia below the T6 level. The other physical examinations were normal. Laboratory tests revealed the treponema pallidum particle agglutination (TPPA) and toluidine red unheated serum test (TRUST) were positive, and the serum rapid plasma reagin (RPR) was 1:16. The antibody against HIV was negative. The levels of homocysteine, folic acid, and vitamin B12 were 26 μmol/L (0-15 μmol/L), 2.59 ng/mL (\>5.4 ng/mL), and 325 pg/mL (211-911 pg/mL), respectively. The results of cerebrospinal fluid test (CSF) showed a higher level of cells (110/μL) and protein (148 mg/dL). The immunological tests of aquaporin 4 (AQP4)-IgG were negative both in serum and CSF. The other inflammatory, immune, and infectious biomarkers both in CSF and serum were also unremarkable. The cranial MRI yielded normal findings. However, the spinal cord MRI showed abnormal longitudinally extensive T2 weighted hyperintensities involving the posterior columns from C7 through T6, with characteristic \"flip-flop sign\" on cervical spinal MRI (Figure [1B and C](#F1){ref-type="fig"}, Figure [2B and C](#F2){ref-type="fig"}). Focal contrast enhancement was observed in the dorsal aspect of the thoracic cord on T1 weighted gadolinium-enhanced images at T3-T4 level (Figures [1C](#F1){ref-type="fig"} and [2C](#F2){ref-type="fig"}).

![Spinal cord magnetic resonance imaging showed abnormal longitudinally extensive T2 weighted hyperintensities involving the posterior columns from C7 through T6, with \"flip-flop sign\" on cervical spinal magnetic resonance imaging.](WJCC-7-1282-g001){#F1}

![Spinal cord magnetic resonance imaging showed abnormal longitudinally extensive T2 weighted hyperintensities involving the posterior columns from C7 through T6, with \"flip-flop sign\" on cervical spinal magnetic resonance imaging. Focal enhancement was observed in the dorsal aspect of the thoracic cord on T1- weighted gadolinium-enhanced images at T3-T4 level.](WJCC-7-1282-g002){#F2}

With the treatment of penicillin (24-million IU/d) for 2 weeks, the symptoms of sensation almost disappeared 3 months later. The abnormal hyperintensities of spinal MRI also resolved at the 3-month follow-up (Figure [3](#F3){ref-type="fig"}). Moreover, the laboratory data of CSF showed reduced cells (24/μL) and protein (65 mg/dL). The findings of TPPA and TRUST (1:8) in serum were still positive. The examination of CSF showed that TPPA was positive and TRUST was 1:1. The diagnosis of syphilitic myelitis was established according to the history of homosexuality, clinical manifestations, MRI findings with typical \"flip-flop sign\", also with the favorable prognosis after the penicillin treatment.

![Abnormal hyperintensities on spinal magnetic resonance imaging also resolved at three-month follow-up.](WJCC-7-1282-g003){#F3}

Our study was approved by the Ethics Committee of Beijing Chaoyang Hospital, Capital Medical University. Written informed consent was obtained from the patient to publish this case.

Literature search and selection
-------------------------------

To better understand the clinical characteristics of syphilitic myelitis, we performed a literature search to identify other reports (reviews, case reports, or case series) from January 1987 to February 2019, using the PubMed and web of science databases with the terms including \"syphilis\", \"neurosyphilis\", \"syphilitic myelitis\", \"menin-gomyelitis\", \"central nervous system\", and \"spine\". All pertinent English-language articles were retrieved. A manual search by reviewing the reference sections of the retrieved articles was also performed.

Data extraction
---------------

Two investigators collected data from the selected articles. The following data were extracted: the author, country, age, gender, symptoms, neurological examination, etiology, auxiliary examinations, therapy, and outcome. We also summarized the clinical characteristics of this rare disorder.

RESULTS
=======

A total of 16 articles of 20 cases between January 1987 and February 2019 were identified by preliminary literature search. The clinical characteristics of the involved cases are presented in Table [1](#T1){ref-type="table"}. Of the 20 patients with syphilitic myelitis, the age of onset varied between 17 and 63 years. Sixteen patients were male (80%). The duration of symptoms was variable from 3 days to 9 months. Sixteen patients presented with the onset of sensory disturbance (80%), 15 with paraparesis (75%), 9 with urinary retention (45%), and 2 with gait disorder (10%). Elven patients had a high risk behavior such as homosexuality or bisexuality (55%). Two patients presented with non-pruritic rash or erythema with the diagnosis of secondary syphilis (10%). One patient was diagnosed with syphilis and had been treated previously (5%). Five patients had concomitant HIV infection (25%). Serological data showed that 15 patients had positive venereal disease research laboratory test (VDRL) and/or high Treponema pallidum hemagglutination (TPHA), and 17 patients had positive VDRL/TPHA in CSF. We also found that the raised protein was seen in 15 patients and pleocytosis was seen in 17 patients in CSF. On MRI, 16 patients showed abnormal signal intensities involving the thoracic spine, 6 involved the cervical spine, and 3 involved both the cervical and thoracic spine. There were 3 patients with the \"flip-flop sign\". All the patients were treated with penicillin, and 15 patients had a good prognosis.

###### 

Clinical features of syphilitic myelitis with longitudinally extensive myelopathy

  **Case series**        **1**                                                  **2**                                                                    **3**                                                           **4**                                        **5**              **6**                                  **7**                                            **8**                                                               **9**                                                                      **10**                                         **11**                                          **12**                                         **13**                        **14**                                         **15**                                            **16**                                                               **17**                         **18**                                             **19**                                           **20**
  ---------------------- ------------------------------------------------------ ------------------------------------------------------------------------ --------------------------------------------------------------- -------------------------------------------- ------------------ -------------------------------------- ------------------------------------------------ ------------------------------------------------------------------- -------------------------------------------------------------------------- ---------------------------------------------- ----------------------------------------------- ---------------------------------------------- ----------------------------- ---------------------------------------------- ------------------------------------------------- -------------------------------------------------------------------- ------------------------------ -------------------------------------------------- ------------------------------------------------ -----------------------------------------------------------------
  Ref.                   \[[@B7]\]                                              \[[@B8]\]                                                                \[[@B9]\]                                                       \[[@B9]\]                                    \[[@B10]\]         \[[@B11]\]                             \[[@B12]\]                                       \[[@B13]\]                                                          \[[@B14]\]                                                                 \[[@B15]\]                                     \[[@B16]\]                                      \[[@B17]\]                                     \[[@B4]\]                     \[[@B18]\]                                     \[[@B18]\]                                        \[[@B19]\]                                                           \[[@B20]\]                     \[[@B21]\]                                         \[[@B21]\]                                       Our case
  Age                    46                                                     31                                                                       17                                                              29                                           17                 28                                     63                                               57                                                                  36                                                                         46                                             63                                              38                                             32                            35                                             30                                                49                                                                   41                             36                                                 49                                               25
  Gender                 M                                                      M                                                                        F                                                               F                                            M                  M                                      M                                                F                                                                   M                                                                          M                                              M                                               M                                              M                             M                                              F                                                 M                                                                    M                              M                                                  M                                                M
  Clinical features      Gait, sensory disturbance, dysuria                     Sensory disturbance, paraparesis                                         Paraparesis, sensory disturbance, urinary retention             Numbness, sensory disturbance, paraparesis   Paraplegia         Chorioretinitis, spastic paraparesis   Sensory deficit, weakness, urinary disturbance   Paraplegia, urinary retention                                       Pain, paraparesis                                                          Numbness, pain                                 Pain, weakness                                  Pain, weakness, numbness, retained urination   Tingling, numbness            Acute transverse myelitis                      Acute transverse myelitis                         Gait, paresthesia, loss of pain and temperature, urinary retention   Unconscious, numbness          Paresthesia, ascending paresis in inferior limbs   Loss of bilateral strength, sensory impairment   Sensory disturbance, numbness
  Duration               2 wk                                                   10 d                                                                     8 d                                                             9 mo                                         NA                 180 d                                  60 d                                             3 d                                                                 4 mo                                                                       7 d                                            12 d                                            4 mo                                           4 mo                          2 wk                                           1 mo                                              2 wk                                                                 NA                             NA                                                 NA                                               7 d
  High risk behavior     NA                                                     \+                                                                       \+                                                              \+                                           NA                 \+                                     NA                                               NA                                                                  NA                                                                         \+                                             NA                                              \+                                             \+                            \+                                             NA                                                \+                                                                   \+                             NA                                                 NA                                               \+
  HIV infection          NA                                                     NA                                                                       NA                                                              NA                                           \+                 \-                                     \-                                               \-                                                                  \-                                                                         \-                                             \-                                              \-                                             \-                            \-                                             \-                                                \+                                                                   \+                             \+                                                 \+                                               \-
  Blood VDRL             NA                                                     1:640                                                                    1:4                                                             1:4                                          1:16               NA                                     NA                                               1:8                                                                 Reactive                                                                   1:64                                           1:16                                            RPR (1:128)                                    1:16                          Reactive                                       Non-reactive                                      Reactive                                                             RPR+                           NA                                                 NA                                               TRUST+ RPR (1:16)
  Blood TPHA             NA                                                     \>1:20480                                                                Reactive                                                        Reactive                                     FTA-ABS (1:6400)   NA                                     NA                                               FTA (3+) TPHA (2+)                                                  1:5120                                                                     1:81920                                        Reactive                                        4+                                             1:160                         1:5120                                         1:1280                                            1:2560                                                               \+                             NA                                                 NA                                               \+
  CSF protein (mg/dL)    High                                                   94                                                                       52                                                              54                                           106                94                                     200                                              Normal                                                              243                                                                        72                                             91.70                                           88                                             40                            123                                            57                                                79                                                                   NA                             NA                                                 NA                                               148
  CSF cells (/μL)        Pleocytosis                                            120                                                                      75                                                              20                                           180                120                                    498                                              Pleocytosis                                                         346                                                                        113                                            303                                             18                                             40                            115                                            170                                               202                                                                  NA                             NA                                                 NA                                               110
  CSF VDRL               Reactive                                               1:80                                                                     Non-reactive                                                    Non-reactive                                 NA                 \+                                     \+                                               1:2                                                                 NA                                                                         NA                                             Reactive                                        1:16                                           \+                            Reactive                                       Reactive                                          NA                                                                   \+                             NA                                                 NA                                               NA
  CSF TPHA               Reactive                                               1:5120                                                                   Non-reactive                                                    Reactive                                     FTA-ABS (1:100)    TPHA+                                  NA                                               NA                                                                  FTA-ABS (1:320), TPHA (1:640)                                              NA                                             NA                                              NA                                             NA                            NA                                             NA                                                \+                                                                   NA                             NA                                                 NA                                               NA
  Spinal MRI             High T2 intensity, abnormal Gd-DTPA enhanced           T3/4 wedge-shaped Gd-DTPA enhanced high intensity, swollen spinal cord   Below the C4 diffuse high signal, candle guttering appearance   T1-T11 abnormal signal, flip-flop sign       NA                 T6-T8                                  LETM, Gadolinium enhancement                     Extensive central high T2 signal, enhancement of the dorsal T8-T9   Diffuse high T2 signal, flip-flop sign                                     T2-T6 high signal, focal Gd-DTPA enhancement   T6-T11 high signal, focal Gd-DTPA enhancement   Ventral part on the level of T6--T7            T5-T12 hyperintense signals   Spine-cord edema from D4 to conus medullaris   Spine-cord edema from cervicodorsal up to conus   High-intensity lesions from C4 to T6                                 Spinal cord edema from C3-T1   Signal impairment in the spinal cord (T2-T12)      Diffuse hypersignal at several levels            Longitudinally extensive T2 hyperintensities involving C7 to T6
  Treatment              Antibiotic therapy                                     Penicillin, prednisolone                                                 Penicillin                                                      Penicillin, cephalosporins                   Penicillin         Penicillin, dexamethasone              Penicillin, dexamethasone                        Antibiotic therapy                                                  Penicillin                                                                 Penicillin, methylprednisolone                 Ceftriaxone, methylprednisolone                 Penicillin, prednisolone                       Penicillin                    Procaine penicillin, Methyl prednisole         Procaine penicillin, donapezil                    Penicillin potassium, methylprednisolone                             Penicillin                     Penicillin                                         Penicillin                                       Penicillin
  Follow-up duration     NA                                                     16 d                                                                     14 d                                                            1 mo                                         NA                 NA                                     2 yr                                             4 wk                                                                28 d                                                                       21 d                                           30 d                                            NA                                             14 d                          6 mo                                           Lost                                              2 wk                                                                 1 wk                           NA                                                 NA                                               3 mo
  Status                 Improved                                               Improved                                                                 Complete remission                                              Improved                                     Spasticity         NA                                     Improved                                         Non improved                                                        Improved                                                                   Improved                                       Improved                                        Positive effect                                NA                            Same                                           NA                                                Improved                                                             Improved                       Complete improvement                               Partial improvement                              Improved
  Repeat CSF finding     NA                                                     TPHA (1:2560), VDRL (1:40)                                               Cells 9/μL, protein 38 mg/dL                                    NA                                           Non-reactive       NA                                     NA                                               NA                                                                  Reduced                                                                    N                                              Cells 34/μL, protein 45.4mg/dL                  NA                                             NA                            NA                                             NA                                                NA                                                                   MA                             NA                                                 NA                                               Cells 24/μL, protein 65 mg/dL, TPPA +, TRUST 1:1.
  Repeat blood finding   NA                                                     TPHA (1:10240), VDRL (1:160)                                             NA                                                              NA                                           NA                 NA                                     NA                                               NA                                                                  NA                                                                         VDRL (1:16)                                    RPR (1:4)                                       RPR (1:64)                                     NA                            NA                                             NA                                                NA                                                                   NA                             NA                                                 NA                                               TPPA (+), TRUST (1:8)
  Repeat MRI finding     Disappearance of intramedullary high intensity areas   Reduction in the intensity of lesions                                    Reduction in the intensity of lesions                           Reduction in the intensity of lesions        NA                 NA                                     NA                                               Disappearance of the high signal lesion on T2-weighted images       Gadolinium enhancement disappeared, the high signal intensity diminished   NA                                             Reduction in the intensity of lesions           NA                                             NA                            NA                                             NA                                                Reduction in the size of the cervical and thoracic cord lesions      NA                             NA                                                 NA                                               Dissolved with three months\' follow up

M: Male; F: Female; NA: Not applicable; VDRL: Venereal disease research laboratory; TPHA: Treponema pallidum hemagglutination assay; LETM: Longitudinally extensive transverse myelitis; RPR: Rapid plasma regain; TRUST: Toluidine red unheated serum test; T: Thoracic; C: Cervical; CSF: Cerebrospinal fluid; HIV: Human immunodeficiency virus; NA: Not applicable; FTA-ABS: Fluorescent treponemal antibody-absorption; +: Positive.

DISCUSSION
==========

Syphilitic myelitis caused by *Treponema pallidum* is an extremely rare disease. Herein, we report a rare case in a 25-year-old young man presenting with symptoms of sensory disturbance, due to syphilitic myelitis with longitudinally extensive myelopathy with typical \"flip-flop sign\" on spinal MRI. Furthermore, we also summarized the clinical features of syphilitic myelitis with longitudinally extensive myelopathy.

In the pre-antibiotic era, syphilis was one of the most frequent causes of myelopathy\[[@B22]\]. Syphilitic meningomyelitis represents less than 3% of neurosyphilitic cases. The diagnosis is based on a high CSF white blood cell count (≥ 20 mL) with either a reactive CSF VDRL test or a positive CSF antibody\[[@B15]\]. Syphilitic myelitis is a very rare but not well-recognized manifestation of neurosyphilis. It is a form of meningo-vascular syphilis with abnormalities confined to the spinal cord. The patients can present with sensory disturbance, lower extremity weakness, pyramidal signs, and variable degrees of bladder and bowel dysfunction. Diagnosis is difficult as it may mimic idiopathic transverse myelitis, spinal cord infarction, and acute disseminated encephalomyelitis, or neuromyelitis optica spectrum disorders (NMOSD). On spinal MRI, longitudinally extensive myelopathy is common, especially the feature of \"flip-flop sign\". Our case further suggested that the presence of "flip-flop sign" may indicate syphilitic myelitis.

Syphilis is a sexually transmitted and systemic disease, and the most common mechanism of transmission is sexual intercourse. HIV and syphilis affect similar patient groups and co-infection is common. The neurological complications of both infections occasionally occur during a clinical course. In the United States, 16% of all syphilis patients, and 28% of male syphilis patients were co-infected with HIV\[[@B23]\]. If syphilis is detected in a patient with an elevated CSF TPHA-albumin index, it is crucial to check for serum HIV antibodies. As for our finding, 11 (55%) patients had a high risk behavior, such as homosexual and/or bisexual individuals. Five patients had concomitant HIV infection (25%). Determining which of the infections, syphilis or HIV, is crucial for allowing for a prompt diagnosis and the initiation of appropriate treatment. Our case further raised the importance of the serious consequences of homosexuality or high risk of unprotected sexual intercourse.

Although there are several hypotheses, the exact origin of the disease remains unknown\[[@B24]\], which may be due to reversible edema from infection or ischemia\[[@B13]\]. In syphilitic myelitis, there is primary involvement of the meninges and vessels. It is pathologically characterized by meningeal inflammation and spinal cord ischemia and edema due to syphilitic vasculopathy. The MRI abnormalities of the spinal cord probably result from meningeal inflammation and spinal cord ischemia. Spinal cord lesions which have resolved completely following treatment have been reported, and the disappearance of high-signal lesion may indicate that ischemic or inflammatory changes are reversible\[[@B13]\]. As for our case, the high intensity areas on T2-weighted imaging may indicate reversible ischemic change or inflammation\[[@B7]\].

The strengths of our case are listed as follows. First, our case revealed extensive T2-weighted abnormal signals in the spinal cord with \"flip-flop sign\". To the best of our knowledge, only two cases have been previously described of such longitudinally extensive T2-weighted hyperintensities with \"flip-flop sign\"\[[@B9],[@B14]\]. Thus, the technique of MRI could be of great importance to explore such disorders\[[@B25]\]. Second, the medical history of homosexuality, clinical presentations, physical examination, laboratory examinations of serum and CSF, imaging findings of \"flip-flop sign\", good effect of penicillin, and favorable prognosis all contributed to our diagnosis of syphilitic myelitis. Moreover, in view of the longitudinally extensive myelopathy on MRI, we also tested AQP4 both in CSF and serum timely. The results were negative, and the misdiagnosis of NMOSD was avoided. Third, to date, our study is the largest study to explore the clinical features of syphilitic myelitis with longitudinally extensive myelopathy on spinal MRI.

In summary, syphilitic myelitis is a very rare manifestation of neurosyphilis. Early diagnosis and treatment are crucial because it represents a treatable and potentially reversible cause of myelopathy with penicillin. Our study also raises awareness of an important complication of neurosyphilis due to homosexuality. Attention is drawn upon the importance of doing serological tests for syphilis when any atypical neurological situation is presented.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Syphilitic myelitis caused by *Treponema pallidum* is an extremely rare disease. However, symptomatic neurosyphilis, especially syphilitic myelitis, and its clinical features have been infrequently reported.

Research motivation
-------------------

Only a few cases of syphilitic myelitis have been documented in the international literature. To the best of our knowledge, there are only 19 reported cases of syphilitic myelitis in the literature.

Research objectives
-------------------

Our study was aimed to summarize the clinical features of syphilitic myelitis with longitudinally extensive myelopathy.

Research methods
----------------

First, we report a patient who suffered from syphilitic myelitis with symptoms of sensory disturbance, with longitudinally extensive myelopathy with \"flip-flop sign\" on spinal magnetic resonance imaging (MRI). This patient experienced complete clinical and radiologic recovery after treatment. Second, we summarized the clinical features of syphilitic myelitis with longitudinally extensive myelopathy.

Research results
----------------

A total of 16 articles of 20 cases were identified. Sixteen patients presented with the onset of sensory disturbance (80%), 15 with paraparesis (75%), and 9 with urinary retention (45%). Eleven patients had a high risk behavior (55%). Five patients had concomitant HIV infection (25%). Serological data showed that 15 patients had positive venereal disease research laboratory test (VDRL)/treponema pallidum particle agglutination (TPHA), and 17 patients had positive VDRL/TPHA in cerebrospinal fluid (CSF). Seventeen patients had elevated cells and protein in CSF. On MRI, 16 patients showed abnormal signal intensities involving the thoracic spine, 6 involved the cervical spine, and 3 involved both cervical and thoracic spine. There were 3 patients with the \"flip-flop sign\". All the patients were treated with penicillin, and 15 patients had a good prognosis.

Research conclusions
--------------------

Our case raises awareness of syphilitic myelitis as an important complication of neurosyphilis due to homosexuality, especially in developing countries.

Research perspectives
---------------------

Attention is drawn upon the importance of doing serological tests for syphilis when any atypical neurological situation is presented. A high index of suspicion is necessary so that this potentially treatable disease would not be overlooked.
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